Cronos Group: Raymond James Sees US$4.10/Share Valuation Just For Ginkgos Partnership
Raymond James recently upgraded Cronos Group (TSX: CRON) (NASDAQ: CRON) to an Outperform 2 rating as well as almost doubling
Read more
Cronos Group
Are Big Liquor And Tobacco Bankrolling Cannabis, Or Killing It?
Markets have been unkind to cannabis investors, and made certain fundamentals-based business bloggers, who were well-hated at the peak of
Read more
Cronos Reports First Quarter Revenues of $8.4 Million, Writes Off $8.0 Million In Inventory
Cronos Group (TSX: CRON) (NASDAQ: CRON) reported its first quarter 2020 financial results early this morning, with revenues of US$8.4
Read more
Cronos Group Posts Revenues of US$7.3 Million For Q4 2019, Loss of US$63.8 Million
Cronos Group (TSX: CRON) (NASDAQ: CRON) has finally reported its fourth quarter and full fiscal year 2019 financial results after
Read more
Cronos Group Subject Of SEC Inquiry
This evening, MarketWatch reporter Max Cherney broke the story that Cronos Group (TSX: CRON) (NASDAQ: CRON) has received inquiries from
Read more
Cronos Group Further Delays Filings, Reduces Prior Revenue Figures By $7.6 Million
Cronos Group (TSX: CRON) (NASDAQ: CRON) announced this evening that further to it’s previous release, the company will be delaying
Read more
Is 2020 The Year Cannabis Extractors Come Down With The Cronos Virus?
Our sharp-eyed editor Jay pointed out last week that cannabis cultivator Cronos Group Inc. (TSX: CRON) (NASDAQ: CRON)‘s delay in
Read more
Is The Medipharm Labs Supply Arrangement The Source Of Cronos’ Late Filings?
Earlier this week, Cronos Group (TSX: CRON) (NASDAQ: CRON) quietly announced that they would delay the filing of their full
Read more
Cronos Group Fails To File Timely Financials Due To Revenue Review
Cronos Group (TSX: CRON) (NASDAQ: CRON) filed its annual report this evening, also known as a 10-K with the Securities
Read more
Heritage Cannabis Director Resigns Just Ahead Of Year End
When we last checked in with our favorite Canadian extraction play Heritage Cannabis (CSE:CANN) in December, the company was touting
Read more